San Francisco, CA (PRWEB) September 17, 2004 --
SENT AS A COURTESY OF:
WORLD NATURAL HEALTH ORGANIZATION
http://www.wnho.net - Click on Racketeering Banner
National Press Conference held Thursday 9/16 at
Sheraton Grand Hotel, Sacramento, Ca
Filed In: The United States District Court for the Northern District of California
Plaintiff: Joe Bellon, individually and as a representative of a class of plaintiffs
Damages $350,000,000
Click to see video: Rumsfeld/Aspartame
http://www.soundandfury.tv/Pages/Rumsfeld.html
A RACKETEER INFLUENCED & CORRUPT ORGANIZATIONS [RICO]complaint has been filed in U.S. District Court for the Northern District of California. The suit charges the defendants with manufacturing and marketing a deadly neurotoxin unfit for human consumption, while they assured the pubic that aspartame (also known as NutraSweet/Equal) contaminated products are safe and healthful, even for children and pregnant women. Present Secretary of Defense Donald Rumsfeld is mentioned throughout the lawsuit.
As evidence, an explosive affidavit from a former translator for the G.D. Searle Co - the developer of aspartame - will be made public at a National Press Conference on Thursday, September 16 at 11:00 a.m. at the Sheraton Grand Sacramento Hotel, 1230 J Street, Sacramento, California 95814, phone (916) 447-1700.
For 16 years, the FDA denied approval of aspartame because of compelling evidence of its contributing to brain tumors and other serious disabilities. Donald Rumsfeld, present Secretary of Defense in the Bush Administration, left President Ford's administration as Chief of Staff to become the CEO of aspartame producer G D Searle Co. in 1981. Shortly after, Rumsfeld became the CEO, and the day after President Reagan took office, aspartame was quickly approved by FDA Commissioner Arthur Hayes over the objections of the FDA's Public Board of Inquiry. Hayes had been recently appointed by the Reagan Administration. Shortly after aspartame's approval by the FDA, Hayes joined NutraSweet's public relations firm under a ten year contract at $1,000 a day.
Aspartame/NutraSweet was the product of the G. D. Searle Co. In January 1977, the FDA wrote a 33 page letter to U.S. Justice Department Attorney
Sam Skinner: "We request that your office convene a Grand Jury investigation into apparent violations of the Federal Food, Drug and Cosmetic Act." Skinner allowed the Statute of Limitations to run.
Three FDA Commissioners and eight other officers and Skinner took jobs in the aspartame industry.
The Food and Drug Administration once listed 92 adverse reactions from 10,000 consumer complaints and would send the list to all inquirers. In 1996 the FDA stopped taking complaints and now denies existence of the report. Seizures, blindness, sexual dysfunction, obesity, testicular, mammary and brain tumors and death, plus dozens of other dread diseases named in the suit arise from the consumption of this neurotoxin.
Defendant Moser, past CEO of NutraSweet, is cited for misrepresenting facts to public and commercial users with full knowledge of the deceptions. The toxin is sold to Bayer, Con Agra Foods, Dannon, Smucker, Kellogg, Wrigley, PepsiCo, Kraft Foods (Crystal Light), Conopco (Slim-Fast), Coke, Pfizer, Wal-Mart and Wyeth (to name a few), who use it in some of their products, including children's vitamins. These entities are named in other suits now in California Courts.
Defendant American Diabetes Association's mission is to care for diabetics. A 35 year ADA member, diabetic specialist H.J.Roberts, M.D.FACP discovered aspartame can precipitate or aggravate diabetes and its complications, or simulate the complications (especially neuropathy and retinopathy). His report, intended for the Annual Scientific Meeting of the ADA, was rejected for presentation - and even publication of the abstract (!) - but was then published in another scientific medical journal.
The seven count indictment includes charges for violation of California Consumers Legal Remedies Act, Fraud, violations of California Civil Code §1780-1784 and Injunctive Relief: that Defendants be enjoined from future use/sale of aspartame.
